“We're not saying a blanket stop for all patients, but I think we do need to be taking each patient as an individual in terms of their backgrounds,” says Jai Seth, MD.
In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Jai Seth, MD. He discusses onabotulinumtoxinA injection programs as a treatment for urinary incontinence and the bleeding risk associated with these injections for patients who also take blood thinners. Seth is a consultant urological surgeon at St. George’s University hospital, London, UK.
Peroneal electrical transcutaneous neuromodulation is found safe and effective in OAB
March 21st 2023"The results of this study demonstrate that peroneal eTNM using the URIS neuromodulation system is safe, well tolerated, and effective, with over 85% of patients experiencing clinically significant improvement in most bothersome OAB symptoms," says Jan Krhut, PhD.
The evolving landscape of urethral bulking agents: Current practices in review
February 3rd 2023Yu Zheng, MD, and Eric Rovner, MD, physicans in the Department of Urology, Medical University of South Carolina provided an important apprasial of urethral bulking agents for stress urinary incontience in women in a recently published review.
2 Clarke Drive
Cranbury, NJ 08512